Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
An Open Label Study to Evaluate the Safety of Dasatinib in the Treatment of Scleroderma Pulmonary Interstitial Fibrosis An Open Label Study to Evaluate the Safety of Dasatinibin the Treatment of Scleroderma Pulmonary Int ...